JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES (original) (raw)

REFERENCES

1

Nicholson NC, Ramp WK, Kneisl JS, et al. Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro. CORR 1998;347:250-60.

2

Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary, National Center for Health Statistics Vital Health. Adv Data 2002;(328):1-32.

3

Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012;50(1):1-12.

4

Hsueh WD, Conley DB, Kim H, et al. Identifying the clinical symptoms for improving the symptomatic diagnosis of chronic rhinosinusitis. Int Forum Allergy Rhinol 2013;3(4):307-14.

5

Ference EH, Tan BK, Hulse KE, et al. Commentary on gender differences in prevalence, treatment and quality of life of patients with chronic rhinosinusitis. Allergy Rhinol (Providence) 2015;6(2):82-8.

6

Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis definitions, diagnosis, epidemiology and pathophysiology. Otolaryngology Head and Neck Surgery 2003;129(3 Suppl)S1-32.

7

Nayak CS, Ray S, Thombre A, et al. Factors affecting the duration of phase I of dexamethasone-cyclophosphamide pulse therapy. Indian J Dermatol Venereol Leprol 2014;80(4):296-9.

8

Kanwar AJ, De D. Pemphigus in India. Indian J Dermatol Venereol Leprol 2011;77(4):439-49.

9

Pasricha JS, Gupta R. Pulse therapy with dexamethasone cyclophosphamide in pemphigus. Ind J Dermatol Venereol Leprol 1984;50(5):199-203.

10

Kandan S, Thappa DM. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series. Indian J Dermatol Venereol Leprol 2009;75(4):373-8.

11

Pasricha JS, Poonam. Current regimen of pulse therapy for pemphigus: minor modifications, improved results. Indian J Dermatol Venereol Leprol 2008;74(3):217-21.